Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
Fuster, V; Rydén, LE; Asinger, RW; Cannom, DS; Crijns, HJ; Frye, RL; Halperin, JL; Kay, GN; Klein, WW; Lévy, S; McNamara, RL; Prystowsky, EN; Wann, LS; Wyse, DG; Gibbons, RJ; Antman, EM; Alpert, JS; Faxon, DP; Fuster, V; Gregoratos, G; Hiratzka, LF; Jacobs, AK; Russell, RO; Smith, SC; Klein, WW; Alonso-Garcia, A; Blomström-Lundqvist, C; de Backer, G; Flather, M; Hradec, J; Oto, A; Parkhomenko, A; Silber, S; Torbicki, A; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation); North American Society of Pacing and Electrophysiology.
ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology.
Circulation. 2001; 104(17):2118-2150
Doi: 10.1161/circ.104.17.2118
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Klein Werner
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Find related publications in this database (using NLM MeSH Indexing)
- Aged -
- Aged, 80 and over -
- Algorithms -
- Anti-Arrhythmia Agents - therapeutic use
- Atrial Fibrillation - classification
- Atrial Flutter - diagnosis
- Comorbidity - diagnosis
- Continental Population Groups - diagnosis
- Diagnosis, Differential - diagnosis
- Disease Management - diagnosis
- Electric Countershock - diagnosis
- Electrocardiography - diagnosis
- Female - diagnosis
- Fibrinolytic Agents - therapeutic use
- Humans - therapeutic use
- Male - therapeutic use
- Middle Aged - therapeutic use
- Prevalence - therapeutic use
- Prognosis - therapeutic use
- Risk Assessment - therapeutic use
- Tachycardia - diagnosis
- Thromboembolism - etiology